Chronic intermittent hypobaric hypoxia ameliorates vascular reactivity through upregulating adiponectin expression of PVAT in metabolic syndrome rats. 2023

Fang Cui, and Haichao Mi, and Yue Guan, and Yan Zhu, and Ruotong Wang, and Yanming Tian, and Kaifan Yang, and Yi Zhang
Department of Physiology, Hebei Medical University, Shijiazhuang 050017, P.R. China.

Cumulating evidence demonstrated that chronic intermittent hypobaric hypoxia (CIHH) had beneficial effects on the body. This study investigated the role of perivascular adipose tissue (PVAT) in ameliorating effect of CIHH on vascular reactivity by adiponectin in mesenteric artery of metabolic syndrome (MS) rats. Main methods: 6-week-old male Sprague-Dawley rats were randomly divided into four groups: control (CON), MS model, CIHH treatment, and MS + CIHH treatment group. The size of adipocytes in PVAT was measured by scanning electron microscopy. Serum adiponectin was measured. The microvessel recording technique was used to observe the effect of CIHH on contraction and relaxation in mesenteric artery rings. Also, the expressions of interleukin-1β, tumor necrosis factor-α, adiponectin, AdipoR1, AdipoR2, APPL1, and endothelial nitric oxide synthase (eNOS) were assayed by Western blotting. Key findings: in MS rats, adipocyte size increased, serum adiponectin decreased, contraction reaction increased while relaxation reaction decreased, the expression of pro-inflammatory cytokines was upregulated, while adiponectin was downregulated in PVAT, and the expressions of AdipoR1, AdipoR2, APPL, and phosphorylated-eNOS were downregulated in mesenteric artery. All aforementioned abnormalities of MS were ameliorated in MS + CIHH rats. We concluded that CIHH treatment improves vascular reactivity through upregulating adiponectin expression and downregulating pro-inflammatory cytokine expression of PVAT in MS rats.

UI MeSH Term Description Entries
D008297 Male Males
D000273 Adipose Tissue Specialized connective tissue composed of fat cells (ADIPOCYTES). It is the site of stored FATS, usually in the form of TRIGLYCERIDES. In mammals, there are two types of adipose tissue, the WHITE FAT and the BROWN FAT. Their relative distributions vary in different species with most adipose tissue being white. Fatty Tissue,Body Fat,Fat Pad,Fat Pads,Pad, Fat,Pads, Fat,Tissue, Adipose,Tissue, Fatty
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000860 Hypoxia Sub-optimal OXYGEN levels in the ambient air of living organisms. Anoxia,Oxygen Deficiency,Anoxemia,Deficiency, Oxygen,Hypoxemia,Deficiencies, Oxygen,Oxygen Deficiencies
D017207 Rats, Sprague-Dawley A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company. Holtzman Rat,Rats, Holtzman,Sprague-Dawley Rat,Rats, Sprague Dawley,Holtzman Rats,Rat, Holtzman,Rat, Sprague-Dawley,Sprague Dawley Rat,Sprague Dawley Rats,Sprague-Dawley Rats
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus
D052242 Adiponectin A 30-kDa COMPLEMENT C1Q-related protein, the most abundant gene product secreted by FAT CELLS of the white ADIPOSE TISSUE. Adiponectin modulates several physiological processes, such as metabolism of GLUCOSE and FATTY ACIDS, and immune responses. Decreased plasma adiponectin levels are associated with INSULIN RESISTANCE; TYPE 2 DIABETES MELLITUS; OBESITY; and ATHEROSCLEROSIS. ACRP30 Protein,Adipocyte Complement-Related Protein 30-kDa,Adipocyte, C1q and Collagen Domain Containing Protein,Adipose Most Abundant Gene Transcript 1,apM-1 Protein,Adipocyte Complement Related Protein 30 kDa,apM 1 Protein
D024821 Metabolic Syndrome A cluster of symptoms that are risk factors for CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS. The major components of metabolic syndrome include ABDOMINAL OBESITY; atherogenic DYSLIPIDEMIA; HYPERTENSION; HYPERGLYCEMIA; INSULIN RESISTANCE; a proinflammatory state; and a prothrombotic (THROMBOSIS) state. Cardiometabolic Syndrome,Insulin Resistance Syndrome X,Metabolic Syndrome X,Reaven Syndrome X,Dysmetabolic Syndrome X,Metabolic Cardiovascular Syndrome,Metabolic X Syndrome,Syndrome X, Insulin Resistance,Syndrome X, Metabolic,Cardiometabolic Syndromes,Cardiovascular Syndrome, Metabolic,Cardiovascular Syndromes, Metabolic,Metabolic Syndromes,Syndrome X, Dysmetabolic,Syndrome X, Reaven,Syndrome, Cardiometabolic,Syndrome, Metabolic,Syndrome, Metabolic Cardiovascular,Syndrome, Metabolic X,Syndromes, Cardiometabolic,Syndromes, Metabolic,X Syndrome, Metabolic

Related Publications

Fang Cui, and Haichao Mi, and Yue Guan, and Yan Zhu, and Ruotong Wang, and Yanming Tian, and Kaifan Yang, and Yi Zhang
July 2018, Life sciences,
Fang Cui, and Haichao Mi, and Yue Guan, and Yan Zhu, and Ruotong Wang, and Yanming Tian, and Kaifan Yang, and Yi Zhang
August 2016, Diabetes research and clinical practice,
Fang Cui, and Haichao Mi, and Yue Guan, and Yan Zhu, and Ruotong Wang, and Yanming Tian, and Kaifan Yang, and Yi Zhang
February 2019, Neuroscience bulletin,
Fang Cui, and Haichao Mi, and Yue Guan, and Yan Zhu, and Ruotong Wang, and Yanming Tian, and Kaifan Yang, and Yi Zhang
January 2020, Frontiers in physiology,
Fang Cui, and Haichao Mi, and Yue Guan, and Yan Zhu, and Ruotong Wang, and Yanming Tian, and Kaifan Yang, and Yi Zhang
January 2023, Frontiers in endocrinology,
Fang Cui, and Haichao Mi, and Yue Guan, and Yan Zhu, and Ruotong Wang, and Yanming Tian, and Kaifan Yang, and Yi Zhang
April 2015, Canadian journal of physiology and pharmacology,
Fang Cui, and Haichao Mi, and Yue Guan, and Yan Zhu, and Ruotong Wang, and Yanming Tian, and Kaifan Yang, and Yi Zhang
August 2016, The Chinese journal of physiology,
Fang Cui, and Haichao Mi, and Yue Guan, and Yan Zhu, and Ruotong Wang, and Yanming Tian, and Kaifan Yang, and Yi Zhang
January 2015, Life sciences,
Fang Cui, and Haichao Mi, and Yue Guan, and Yan Zhu, and Ruotong Wang, and Yanming Tian, and Kaifan Yang, and Yi Zhang
May 2013, Canadian journal of physiology and pharmacology,
Fang Cui, and Haichao Mi, and Yue Guan, and Yan Zhu, and Ruotong Wang, and Yanming Tian, and Kaifan Yang, and Yi Zhang
February 2024, The Journal of neuroscience : the official journal of the Society for Neuroscience,
Copied contents to your clipboard!